Ex-Har­vard pro­fes­sor and se­r­i­al en­tre­pre­neur Omid Farokhzad jumps in­to the SPAC game with some in­dus­try in­sid­ers and a cer­tain bil­lion­aire sci­en­tist

Omid Farokhzad is jump­ing in­to the SPAC game, and he’s go­ing in with one of the most ex­pe­ri­enced teams we’ve seen in biotech — an un­usu­al blend of fi­nan­cial and in­dus­try in­sid­ers, deep-pock­et in­vestors and a cer­tain bil­lion­aire sci­en­tist who has played a long­time sup­port role for his for­mer stu­dent.

The for­mer Har­vard pro­fes­sor had been co-founder for a string of biotechs be­fore de­cid­ing to de­vote him­self to a new role as CEO of Seer —where the big idea these past 2 years-plus has been to shift away from ge­nomics in fa­vor of a a pro­teomics plat­form that is do­ing some pop­u­la­tion-wide ex­plo­rations, build­ing a moun­tain of da­ta that can be probed with ma­chine learn­ing tech in search of in­sights in­to dis­eases that can be used to de­vel­op liq­uid biop­sy prod­ucts for ear­ly-stage di­ag­no­sis.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER